Articles published by Merck & Co., Inc.
![](https://mms.businesswire.com/media/20211108006081/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
![](https://mms.businesswire.com/media/20211104005560/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
Merck and Ridgeback’s Molnupiravir, an Oral COVID-19 Antiviral Medicine, Receives First Authorization in the World
November 04, 2021
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK
![](https://mms.businesswire.com/media/20211031005023/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
![](https://mms.businesswire.com/media/20211029005540/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
![](https://mms.businesswire.com/media/20211028005322/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
Merck Announces Third-Quarter 2021 Financial Results
October 28, 2021
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK
![](https://mms.businesswire.com/media/20211027005220/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
![](https://mms.businesswire.com/media/20211027005308/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
![](https://mms.businesswire.com/media/20211025005274/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
![](https://mms.businesswire.com/media/20211025005204/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
![](https://mms.businesswire.com/media/20211022005077/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
![](https://mms.businesswire.com/media/20211020006135/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
![](https://mms.businesswire.com/media/20211019006241/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
![](https://mms.businesswire.com/media/20211015005282/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
![](https://mms.businesswire.com/media/20211015005281/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
![](https://mms.businesswire.com/media/20211013006053/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
![](https://mms.businesswire.com/media/20211012005308/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
Merck Begins Tender Offer to Acquire Acceleron Pharma Inc.
October 12, 2021
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK
![](https://mms.businesswire.com/media/20211011005110/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
![](https://mms.businesswire.com/media/20211005005206/en/906363/5/Yvonne.jpg)
![](https://mms.businesswire.com/media/20211001005189/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
![](https://mms.businesswire.com/media/20210930005314/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
Merck to Acquire Acceleron Pharma Inc.
September 30, 2021
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK
![](https://mms.businesswire.com/media/20210929005873/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
Merck Announces Appointment of Thomas H. Glocer as Independent Lead Director
September 29, 2021
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK
![](https://mms.businesswire.com/media/20210928005210/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
Merck to Hold Third-Quarter 2021 Sales and Earnings Conference Call on October 28
September 28, 2021
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK
![](https://mms.businesswire.com/media/20210927005200/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
![](https://mms.businesswire.com/media/20210924005079/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
![](https://mms.businesswire.com/media/20210919005025/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
![](https://mms.businesswire.com/media/20210918005009/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
![](https://mms.businesswire.com/media/20210918005005/en/907504/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
![](https://mms.businesswire.com/media/20210917005228/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
![](https://mms.businesswire.com/media/20210908005408/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
![](https://mms.businesswire.com/media/20210907005088/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
Merck to Present at the Morgan Stanley 19th Annual Healthcare Conference
September 07, 2021
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.